| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Recursion Pharmaceuticals, Inc. (RXRX) have been net sellers, shedding 127,408 shares worth roughly $546K on balance. In the past 30 days, 0 insiders bought and 2 sold.
Both insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.11M | $23.85M | -50,000 | |
| CEO | 2.07M | $8.09M | - | |
| Dir | 1.48M | $5.77M | - | |
| CFO | 1.07M | $4.18M | - | |
| Other | 1.04M | $4.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2023 | Blake Borgeson68 | Director | Sell | 8,885 | $7.73 | $68,707.71 | -0.1% | +5.3% | +60.4% | |
| Feb 21, 2023 | Mubadala Investment Co Pjsc62 | 10% Owner | Buy | 94,418 | $7.74 | $731,125.78 | +0.8% | +5.3% | +60.4% | |
| Feb 17, 2023 | Mubadala Investment Co Pjsc62 | 10% Owner | Buy | 63,382 | $7.71 | $488,985.79 | +0.5% | -31.5% | +64.6% | |
| Feb 16, 2023 | Mubadala Investment Co Pjsc62 | 10% Owner | Buy | 42,682 | $7.90 | $337,042.68 | +0.3% | -31.2% | +68.2% | |
| Feb 16, 2023 | Shafique Virani70 | Chief Business Officer | Sale+OE | 9,254 | $8.35 | $77,244.94 | -4.7% | -31.2% | +68.2% | |
| Feb 14, 2023 | Mubadala Investment Co Pjsc62 | 10% Owner | Buy | 6,300 | $7.95 | $50,059.80 | - | -32.8% | +31.1% | |
| Feb 13, 2023 | Mubadala Investment Co Pjsc62 | 10% Owner | Buy | 32,474 | $7.97 | $258,837.26 | +0.3% | -29.8% | +22.7% | |
| Feb 10, 2023 | Mubadala Investment Co Pjsc62 | 10% Owner | Buy | 11,000 | $7.98 | $87,807.50 | - | -34.1% | +23.2% | |
| Feb 7, 2023 | Blake Borgeson68 | Director | Sell | 8,885 | $8.81 | $78,262.63 | -0.1% | -36.8% | +3.0% | |
| Feb 2, 2023 | Christopher Gibson71 | Chief Executive Officer | Sell | 21,000 | $9.22 | $193,561.10 | - | -44.9% | -0.9% |